Nurse Practitioner, Adult Health · Brooklyn, NY
NPI
1972985976
Since 2015
Specialty
Nurse Practitioner, Adult Health
Code 363LA2200X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
2898 W 8th St, Apt 11m
Brooklyn, NY, 11224
Phone (718) 336-8855
Groups this clinician bills Medicare through
Medicare paid, 2024
$26K
659 services
Medicare patients, 2024
64
Average age 77
Drug cost, 2024
$2.3M
3,913 prescriptions
Company payments, 2025
$436
From 5 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Dina Krupnik was code 99213 (office e&m - established), 226 times for 60 patients. In total Dina Krupnik billed 659 services in 21 codes, and Medicare paid $26K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2015-06-25.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 226 | 60 | $69.23 | $16K |
| 99212 Office E&M - Established | Office | 106 | 44 | $43.88 | $4,652 |
| 36415 Venipuncture Blood Collection | Office | 90 | 50 | $8.65 | $779 |
| G0447 Face-to-face behavioral counseling for obesity, 15 minutes | Office | 89 | 34 | $24.11 | $2,146 |
| 93000 Electrocardiogram | Office | 30 | 28 | $11.23 | $337 |
| 99211 Office E&M - Established | Office | 19 | 15 | $18.25 | $347 |
By year: 2022 $37K for 770 services; 2023 $35K for 827 services; 2024 $26K for 659 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 90 | 50 | $8.65 | $779 |
Medicare prescription drug claims, 2024
In 2024, the drug Dina Krupnik prescribed most often to Medicare patients was Vascepa (Icosapent Ethyl), with 252 prescriptions and refills. In total Dina Krupnik wrote 3,913 Medicare prescriptions that cost $2.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Vascepa Icosapent Ethyl | 252 | 256 | 35 | $85K |
| Linzess Linaclotide | 195 | 195 | 26 | $98K |
| Diclofenac Sodium Generic | 157 | 157 | 32 | $96K |
| Zenpep Lipase/Protease/Amylase | 153 | 157 | 20 | $299K |
| Ubrelvy Ubrogepant | 141 | 141 | 22 | $154K |
| Atorvastatin Calcium Generic | 122 | 154 | 18 | $395 |
| Amlodipine Besylate Generic | 118 | 144 | 18 | $195 |
| Gabapentin Generic | 93 | 114 | 22 | $361 |
| Jublia Efinaconazole | 91 | 91 | 12 | $116K |
| Rosuvastatin Calcium Generic | 84 | 118 | 20 | $600 |
| Ezetimibe Generic | 77 | 103 | 12 | $652 |
| Nurtec Odt Rimegepant Sulfate | 71 | 72 | 11 | $111K |
| Ztlido Lidocaine | 71 | 71 | 11 | $24K |
| Rybelsus Semaglutide | 71 | 71 | Under 11 | $64K |
| Myrbetriq Mirabegron | 69 | 69 | 12 | $30K |
Brand drugs: 2,275 claims; generic drugs: 1,550 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Dina Krupnik $436 ($436 in general payments such as food, travel and fees) from 5 companies. The largest payer was Axsome Therapeutics, Inc. with $205.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.